In addition to studies on PBMCs from T1D patients, multiple lines of evidence have demonstrated the important roles of both CD4+ and CD8+ effector T cells in the immune response to pancreatic islets that drives T1D. This evidence concerns the gene CD4 and type 1 diabetes mellitus.